Paul J Diaz insider trades: Myriad Genetics (MYGN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Paul reports to the SEC
Open-market buys and sales
38 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 11, 2024 | MYGN | ↓ Sell | 15,000 | $22.93 | $344K | Direct | Oct 11, 2024 (0d) |
| Sep 11, 2024 | MYGN | ↓ Sell | 15,000 | $26.72 | $401K | Direct | Sep 12, 2024 (1d) |
| May 15, 2024 | MYGN | ↓ Sell | 227,844 | $25.14 | $5.7M | Direct | May 15, 2024 (0d) |
| May 18, 2020 | DVA | ↓ Sell | 5,763 | $82.22 | $474K | Direct | May 19, 2020 (1d) |
| Nov 10, 2015 | KND | ↑ Buy | 50,000 | $12.53 | $627K | Direct | Nov 12, 2015 (2d) |
| Mar 6, 2014 | KND | ↓ Sell | 114,000 | $22.06 | $2.5M | Direct | Mar 7, 2014 (1d) |
| Feb 25, 2014 | KND | ↓ Sell | 60,241 | $20.95 | $1.3M | Direct | Feb 26, 2014 (1d) |
| Feb 24, 2014 | KND | ↓ Sell | 60,000 | $20.10 | $1.2M | Direct | Feb 26, 2014 (2d) |
| Feb 20, 2014 | DVA | ↓ Sell | 17,511 | $65.59 | $1.1M | Direct | Feb 24, 2014 (4d) |
| Jun 5, 2013 | KND | ↓ Sell | 61,435 | $13.81 | $848K | Direct | Jun 6, 2013 (1d) |
| Jun 4, 2013 | KND | ↓ Sell | 67,629 | $13.96 | $944K | Direct | Jun 5, 2013 (1d) |
| Sep 28, 2012 | KND | ↓ Sell | 42,467 | $11.42 | $485K | Direct | Oct 2, 2012 (4d) |
| Sep 21, 2012 | KND | ↓ Sell | 24,346 | $12.14 | $296K | Direct | Sep 24, 2012 (3d) |
| Aug 8, 2012 | DVA | ↓ Sell | 9,080 | $96.73 | $878K | Direct | Aug 8, 2012 (0d) |
| May 19, 2011 | DVA | ↓ Sell | 19,192 | $86.68 | $1.7M | Direct | May 23, 2011 (4d) |
| Aug 19, 2009 | KND | ↓ Sell | 8,808 | $14.09 | $124K | Direct | Aug 19, 2009 (0d) |
| Aug 18, 2009 | KND | ↓ Sell | 21,600 | $14.15 | $306K | Direct | Aug 19, 2009 (1d) |
| Aug 17, 2009 | KND | ↓ Sell | 34,400 | $14.07 | $484K | Direct | Aug 18, 2009 (1d) |
| Aug 13, 2009 | KND | ↓ Sell | 18,900 | $14.73 | $278K | Direct | Aug 14, 2009 (1d) |
| Aug 12, 2009 | KND | ↓ Sell | 34,600 | $14.96 | $518K | Direct | Aug 13, 2009 (1d) |
| Aug 11, 2009 | KND | ↓ Sell | 7,904 | $14.76 | $117K | Direct | Aug 12, 2009 (1d) |
| Jun 2, 2008 | KND | ↓ Sell | 42,138 | $27.92 | $1.2M | Direct | Jun 3, 2008 (1d) |
| Jun 2, 2008 | KND | ↓ Sell | 17,800 | $27.38 | $487K | Direct | Jun 3, 2008 (1d) |
| Jun 2, 2008 | KND | ↓ Sell | 6,150 | $28.18 | $173K | Direct | Jun 3, 2008 (1d) |
| May 30, 2008 | KND | ↓ Sell | 33,551 | $27.60 | $926K | Direct | Jun 2, 2008 (3d) |
| May 30, 2008 | KND | ↓ Sell | 9,500 | $28.19 | $268K | Direct | Jun 2, 2008 (3d) |
| May 29, 2008 | KND | ↓ Sell | 12,300 | $28.10 | $346K | Direct | Jun 2, 2008 (4d) |
| Jul 28, 2005 | KND | ↓ Sell | 3,550 | $39.31 | $140K | Direct | Aug 1, 2005 (4d) |
| Jul 28, 2005 | KND | ↓ Sell | 200 | $39.13 | $8K | Direct | Aug 1, 2005 (4d) |
| Jul 27, 2005 | KND | ↓ Sell | 3,550 | $39.39 | $140K | Direct | Jul 28, 2005 (1d) |
| Jul 27, 2005 | KND | ↓ Sell | 200 | $39.28 | $8K | Direct | Jul 28, 2005 (1d) |
| Jul 13, 2005 | KND | ↓ Sell | 3,750 | $39.57 | $148K | Direct | Jul 15, 2005 (2d) |
| Jul 12, 2005 | KND | ↓ Sell | 3,350 | $40.61 | $136K | Direct | Jul 14, 2005 (2d) |
| Jul 12, 2005 | KND | ↓ Sell | 400 | $40.78 | $16K | Direct | Jul 14, 2005 (2d) |
| Jun 13, 2005 | KND | ↓ Sell | 11,400 | $40.06 | $457K | Direct | Jun 15, 2005 (2d) |
| Jun 10, 2005 | KND | ↓ Sell | 59,256 | $39.93 | $2.4M | Direct | Jun 13, 2005 (3d) |
| May 31, 2005 | KND | ↓ Sell | 500 | $38.48 | $19K | Direct | Jun 1, 2005 (1d) |
| May 27, 2005 | KND | ↓ Sell | 25,786 | $37.51 | $967K | Direct | May 31, 2005 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MYGN insiders
Open-market trades in the last 12 months
About Paul J Diaz's insider trades
Paul J Diaz is President and CEO at Myriad Genetics (MYGN). Since May 27, 2005, Paul has reported 1 open-market purchase worth $627K and 37 sales worth $27.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (134 filings), shares withheld for taxes (67 filings), option exercises (16 filings), gifts (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MYGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.